ReSolve Research Solutions, Inc. Competitors

FOMAT Medical Research is a pioneering research site network based in California, known for its extensive network and commitment to improving patient outcomes through clinical research. By focusing on diversity and innovation, FOMAT collaborates with industry leaders to expedite the development of new therapies across various therapeutic areas. As a prominent member of hyperCORE International, FOMAT leverages global resources to advance healthcare solutions.OUR COMPREHENSIVE TEAMS INCLUDE: • Network of physicians and specialists providing access to over 100K patients in California.• 50+ investigators, 26 sites• 250+ clinical trials• Dedicated Clinical Research Coordinators for phases I–IV trialsAWARDS AND RECOGNITION:• Finalist for the Top 3 Site Patient Recruitment Innovation Award (SPRIA) by the Society of Clinical Research Sites (SCRS) in 2022.• Awarded Innovative Business of the Year by the Oxnard Chamber of Commerce in 2020.• Top 3 Finalist at the ViE Awards for Best Clinical Research Network in 2022 and 2024, affiliated with hyperCORE.LOCATIONS:Oxnard, CAVentura, CACamarillo, CAWest Lake Village, CASimi Valley, CAArcadia, CAPasadena, CATemple City, CARosemead, CAMonrovia, CASanta Maria, CASalinas, CAGreenfield, CAOUR THERAPEUTIC AREAS:Allergy and Immunology, Cardiology, Dermatology, Family Medicine, Gastroenterology, Internal Medicine and Vaccines, Nephrology, Nephrology, Obstetrics and Gynecology, Ophthalmology, Oncology, Pediatrics, Rheumatology, Urology

Horizon BioAdvance is a biomedical research company in Lafayette, Ind., with multiple specialties in clinical and translational research. At Horizon, we offer a comprehensive package of clinical and research support to our patients, researchers, and sponsors.

Pharmatech, Inc. is a Site Management Organization (SMO) that specializes in creating efficiencies in the clinical trial process. Through an organized network of clinics, the Company focuses on advancing the development of products for a broad range of pharmaceutical and biotechnology companies, and on promoting the inclusion of clinical trials in the spectrum of patient treatment options.